Tokyo - Delayed Quote JPY
Rohto Pharmaceutical Co.,Ltd. (4527.T)
2,123.00
-55.50
(-2.55%)
At close: 3:30:00 PM GMT+9
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
270,840,000
270,840,000
238,664,000
199,646,000
181,053,000
Cost of Revenue
113,554,000
113,554,000
101,243,000
83,476,000
74,326,000
Gross Profit
157,285,000
157,285,000
137,421,000
116,170,000
106,726,000
Operating Expense
117,233,000
117,233,000
103,457,000
87,151,000
83,732,000
Operating Income
40,052,000
40,052,000
33,964,000
29,019,000
22,994,000
Net Non Operating Interest Income Expense
1,327,000
1,327,000
715,000
120,000
196,000
Pretax Income
41,518,000
41,518,000
34,290,000
27,874,000
23,006,000
Tax Provision
10,123,000
10,123,000
7,860,000
6,686,000
6,236,000
Net Income Common Stockholders
30,936,000
30,936,000
26,377,000
21,127,000
16,743,000
Diluted NI Available to Com Stockholders
30,936,000
30,936,000
26,377,000
21,127,000
16,743,000
Basic EPS
135.61
135.61
115.62
92.61
73.39
Diluted EPS
135.21
135.21
115.29
92.34
73.18
Basic Average Shares
228,124.77
228,124.77
228,139
228,140
228,140
Diluted Average Shares
228,799.65
228,799.65
228,788.27
228,795.76
228,792.02
Total Operating Income as Reported
40,048,000
40,048,000
33,959,000
29,015,000
22,990,000
Total Expenses
230,787,000
230,787,000
204,700,000
170,627,000
158,058,000
Net Income from Continuing & Discontinued Operation
30,936,000
30,936,000
26,377,000
21,127,000
16,743,000
Normalized Income
31,695,780
31,695,780
27,119,473
22,667,495
18,146,325
Interest Income
1,523,000
1,523,000
962,000
368,000
341,000
Interest Expense
196,000
196,000
247,000
248,000
145,000
Net Interest Income
1,327,000
1,327,000
715,000
120,000
196,000
EBIT
41,714,000
41,714,000
34,537,000
28,122,000
23,151,000
EBITDA
50,401,000
50,401,000
42,338,000
35,811,000
29,899,000
Reconciled Cost of Revenue
113,554,000
113,554,000
101,243,000
83,476,000
74,326,000
Reconciled Depreciation
8,687,000
8,687,000
7,801,000
7,689,000
6,748,000
Net Income from Continuing Operation Net Minority Interest
30,936,000
30,936,000
26,377,000
21,127,000
16,743,000
Total Unusual Items Excluding Goodwill
-1,005,000
-1,005,000
-963,000
-2,035,000
-1,925,000
Total Unusual Items
-1,005,000
-1,005,000
-963,000
-2,035,000
-1,925,000
Normalized EBITDA
51,406,000
51,406,000
43,301,000
37,846,000
31,824,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-245,220
-245,220
-220,527
-494,505
-521,675
3/31/2021 - 1/4/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade